| Article | Date | Source |
|---|
| Convalescent Plasma Levels of TAFI Activation Peptide Predict Death and Recurrent Vascular Events in Ischemic Stroke Survivors | January 20, 2012 | Pharmaceutical - Moreover |
| Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection | November 07, 2011 | Pharma News - PR Newswire |
| Targeting Zymogen Activation To Control the Matriptase-Prostasin Proteolytic Cascade | October 13, 2011 | Pharmaceutical - Moreover |
| Nobel Prize for Physiology or Medicine Shared Between Discoverers of Innate Immunity Activation and Dendritic Cells | October 03, 2011 | Inside Industry - Gen |
| On-Demand Electrochemical Activation of the Click Reaction on Self-Assembled Monolayers on Gold Presenting Masked Acetylene Groups | October 01, 2011 | Biotechnology - Moreover |
| Catalytic Syntheses of N-Heterocyclic Ynones and Ynediones by In Situ Activation of Carboxylic Acids with Oxalyl Chloride | September 09, 2011 | Pharmaceutical - Moreover |
| Understanding the villain: DMBA induced pre-antral ovotoxicity involves selective follicular destruction and primordial follicle activation through PI3K/Akt and mTOR signalling | July 24, 2011 | Biotechnology - Moreover |
| Biogen Idec, Inc. (Massachusetts) Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis | July 06, 2011 | BioSpace - Breaking News |
| Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis | July 03, 2011 | Pharma News - Business Wire |
| Les chercheurs de Biogen Idec identifient une nouvelle approche favorisant la remyélinisation et inhibant l’activation autoimmune, laquelle pourrait éventuellement constituer une option thérapeutique pour le traitement de la sclérose en plaques | July 03, 2011 | Pharma News - Business Wire |
| Keynote Presentation at Leading European Antibody Conference Highlights Immune Reactivation Mechanisms of Bavituximab | May 26, 2011 | Marketwire - Pharma and Biotech |
| Inactivation of the Indigenous Methyltransferase RlmN in Staphylococcus aureus Increases Linezolid Resistance [Mechanisms of Resistance] | May 18, 2011 | Biotechnology - Moreover |
| A Novel Monocarbonyl Analogue of Curcumin, (1E,4E)-1,5-Bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, Induced Cancer Cell H460 Apoptosis via Activation of Endoplasmic Reticulum Stress Signaling Pathway | May 17, 2011 | Pharmaceutical - Moreover |
| Fragment of RegeneRx’s Tß4 Inhibits Activation of Liver Cells Responsible Fibrosis & Scar Formation | April 12, 2011 | Pharma News - PharmiWeb |
| Fragment of RegeneRx’s Tβ4 Inhibits Activation of Liver Cells Responsible Fibrosis & Scar Formation | April 11, 2011 | Pharma News - Business Wire |
| Search for New Paradigm of Pre-Emptive Pathogen Reduction and Pathogen Inactivation to Infuse High Growth Into European Blood Pathogen Inactivation Market, Says Frost & Sullivan | March 22, 2011 | Marketwire - Pharma and Biotech |
| Cytokinetics, Inc. Announces Fundamental Research in the Field of Cardiac Myosin Activation Published in the Journal Science | March 18, 2011 | BioSpace - Breaking News |
| Cytokinetics Announces Fundamental Research in the Field of Cardiac Myosin Activation Published in the Journal Science | March 18, 2011 | Marketwire - Pharma and Biotech |
| A Domino Process for Benzyne Preparation: Dual Activation of o-(Trimethylsilyl)phenols by Nonafluorobutanesulfonyl Fluoride | March 12, 2011 | Pharmaceutical - Moreover |
| ViroStatics Demonstrates Clinical Proof of Concept for Dual Antiviral Anti-Hyperactivation AV-HALT Drugs | March 01, 2011 | Pharma News - Business Wire |
| Maven Semantic: Lymphocyte Activation Research Database (BIZ) | January 05, 2011 | Pharmaceutical - Moreover |
| Maven Semantic: Lymphocyte Activation Research Database | January 04, 2011 | Biotech News - Business Wire |
| Nostrum Pharmaceuticals Licenses Clinical Development and Worldwide Commercialization Rights From for Novel, Next-Generation Thrombolytics With Clot Specific Activation and Re-occlusion Prevention Properties | November 29, 2010 | BioSpace - Breaking News |
| Nostrum Pharmaceuticals, LLC Licenses Clinical Development and Worldwide Commercialization Rights From IMTECH, India, for Novel, Next-Generation Thrombolytics With Clot Specific Activation and Re-occlusion Prevention Properties | November 24, 2010 | Pharma News - PR Newswire |
| UV Flu Technologies Announces UV-400 Air Purifier Delivers Favorable Preliminary Test Results for the Inactivation of Viruses | November 11, 2010 | Marketwire - Pharma and Biotech |
| Cerus to Raise $21M through Public Offering for Blood Pathogen Inactivation System | November 10, 2010 | Inside Industry - Gen |
| Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage | October 13, 2010 | Biotechnology - Moreover |
| Cerus Awarded $1.4 Million to Advance Development of Pathogen Inactivation for Red Blood Cells | September 23, 2010 | Biotech News - Business Wire |
| Substituted 4-Carboxymethylpyroglutamic Acid Diamides as Potent and Selective Inhibitors of Fibroblast Activation Protein | September 10, 2010 | Biotechnology - Moreover |
| Whittemore Peterson Institute and Cerus Corporation Announce Inactivation of XMRV in Platelets and Red Blood Cells by the INTERCEPT Blood System | September 07, 2010 | BioSpace - Breaking News |
| Whittemore Peterson Institute and Cerus Announce Inactivation of XMRV in Platelets and Red Blood Cells by the INTERCEPT Blood System | September 07, 2010 | Biotech News - Business Wire |
| Geron Corporation Provides Update on Telomerase Activation Program | July 15, 2010 | BioSpace - Breaking News |
| Geron Provides Update on Telomerase Activation Program | July 15, 2010 | Pharma News - Business Wire |
| Plexxikon’s Novel Agent Significantly Inhibits Activation of Key CNS Cells Associated With Alzheimer’s Disease | July 14, 2010 | Pharma News - Business Wire |
| Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3beta release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells - Abstract | July 08, 2010 | Biotechnology - Moreover |
| Interactivation Health Networks Bolsters Out-of-Home Ad Sales Team With Addition of Seasoned Account Executive | June 29, 2010 | Marketwire - Pharma and Biotech |
| Kendle Advances Early Stage Drug Development with ElMindA's Innovative Brain Network Activation Technology | June 15, 2010 | Pharma News - PR Newswire |
| Whittemore Peterson Institute and Cerus Confirm Inactivation of XMRV by the INTERCEPT Blood System | May 18, 2010 | Biotech News - Business Wire |
| ASP Sterrad Technology Approved by AFSSAPS for Total Inactivation of Prions | April 27, 2010 | Biotech News - PR Newswire |
| Discovery of Enzyme Activation Process Could Lead to New Heart Attack Treatments, Indiana University And Stanford University Study | January 11, 2010 | BioSpace |
| Estrogen Receptor Activation Predicts Tamoxifen Response, Lund University And University of Manchester Study | November 30, 2009 | BioSpace |
